Original Research
Published on 20 Sep 2024
A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1)
in Pharmacoepidemiology
- 910 views
- 1 citation
Original Research
Published on 20 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 19 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 19 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 16 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 16 Sep 2024
in Pharmacoepidemiology
Systematic Review
Published on 13 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 10 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 09 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 06 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 04 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 04 Sep 2024
in Pharmacoepidemiology
Original Research
Published on 29 Aug 2024
in Pharmacoepidemiology
Systematic Review
Published on 23 Aug 2024
in Pharmacoepidemiology
Original Research
Published on 22 Aug 2024
in Pharmacoepidemiology
Editorial
Published on 20 Aug 2024
in Pharmacoepidemiology
Original Research
Published on 13 Aug 2024
in Pharmacoepidemiology